| JIUZHOU-PHARMACY |
JIUZHOU-PHARMACY |
92%
|
Sales to Jiuzhou Pharmacy currently account for over 60% of the Company’s revenue and are expected to remain a significant source of revenue in the near term. |
| HANGZHOU-XIAORAN-PHARMACEUTICAL-CO-LTD |
HANGZHOU-XIAORAN-PHARMACEUTICAL-CO-LTD |
85%
|
e to make deliveries as necessary. Competition The wholesale pharmaceutical distribution industry in China is competitive and highly fragmented. We compete with regional distributors, such as Zhengch… |
| ZHENGCHEN-PHARMACEUTICAL-CO-LTD |
ZHENGCHEN-PHARMACEUTICAL-CO-LTD |
85%
|
e to make deliveries as necessary. Competition The wholesale pharmaceutical distribution industry in China is competitive and highly fragmented. We compete with regional distributors, such as Zhengch… |
| AN-JIUZHOU-PHARMACY-CO-LTD |
AN-JIUZHOU-PHARMACY-CO-LTD |
62%
|
icensed doctors of both western medicine and TCM on site for consultation, examination and treatment of common ailments at scheduled hours. During the year ended March 31, 2021, the Company sold its … |
| CHINA-JO-JO-DRUGSTORES-HOLDINGS-INC |
CHINA-JO-JO-DRUGSTORES-HOLDINGS-INC |
62%
|
Equity Exchange Agreement with Mr. Lingtao Kong and Ridgeline, pursuant to which the Company acquired from Mr. Kong all of the issued and outstanding ordinary shares of Ridgeline, the direct parent c… |
| CHINA-JO-JO-DRUGSTORES-INC |
CHINA-JO-JO-DRUGSTORES-INC |
62%
|
,577 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid for income taxes $ 149,023 $ 63,668 $ 3,955 Cash paid for interest 13,604 64,943 262,218 NON-CASH ACTIVITIES： Cashless exercise of war… |
| CT-CORPORATION |
CT-CORPORATION |
62%
|
e ending balances owed to/from the VIEs were eliminated in the balance sheets. Below are the amounts of purchases by Jiuxin Medicine from Jiuzhou Pharmacy during the interim period of the latest comp… |
| EQUINITI-TRUST-COMPANY |
EQUINITI-TRUST-COMPANY |
62%
|
ort. Our transfer agent is Equiniti Trust Company, , LLC, whose address is 48 Wall Street, Floor 23 New York, NY 10005, and whose telephone number is (800) 468-9716. The SEC maintains an internet sit… |
| EQUINITI-TRUST-COMPANY-LLC |
EQUINITI-TRUST-COMPANY-LLC |
62%
|
Item 1 “ Business ” - “ Contractual Arrangements with HJ Group and the Key Personnel .” Corporate Information Our principal executive office is located at 5th Floor, Building 6, No. 100, 18th Street,… |
| FENGWODA-PHARMACEUTICAL-CO-LTD |
FENGWODA-PHARMACEUTICAL-CO-LTD |
62%
|
e to make deliveries as necessary. Competition The wholesale pharmaceutical distribution industry in China is competitive and highly fragmented. We compete with regional distributors, such as Zhengch… |
| FOREIGN-INVESTMENT-INDUSTRIES |
FOREIGN-INVESTMENT-INDUSTRIES |
62%
|
eutical business have obtained necessary pharmaceutical distribution permits, and we do not expect to face any difficulties in renewing these permits and/or certifications. In addition, under the Sup… |
| HANGZHOU-JIUTONG-MEDICAL-TECHNOLOGY-CO-LTD |
HANGZHOU-JIUTONG-MEDICAL-TECHNOLOGY-CO-LTD |
62%
|
,577 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid for income taxes $ 149,023 $ 63,668 $ 3,955 Cash paid for interest 13,604 64,943 262,218 NON-CASH ACTIVITIES： Cashless exercise of war… |
| HANGZHOU-JIUZHOU-GRAND-PHARMACY-CHAIN-CO-LTD |
HANGZHOU-JIUZHOU-GRAND-PHARMACY-CHAIN-CO-LTD |
62%
|
erate our pharmacies (including the medical clinics) through the following companies in China that we manage through contractual arrangements (refer to “ Contractual Arrangements with HJ Group and th… |
| HANGZHOU-QIANHONG-AGRICULTURE-DEVELOPMENT-CO-LTD |
HANGZHOU-QIANHONG-AGRICULTURE-DEVELOPMENT-CO-LTD |
62%
|
rol contractually, operates our “Jiuzhou Grand Pharmacy” stores; ● Hangzhou Jiuzhou Clinic of Integrated Traditional and Western Medicine (General Partnership) (“Jiuzhou Clinic”), which we control co… |
| HEALTH-MANAGEMENT-CO-LTD |
HEALTH-MANAGEMENT-CO-LTD |
62%
|
C are covered by insurance up to RMB 500,000 (USD 79,600 ) per bank. As of March 31, 2024 and 2023, the Company had deposits totaling $ 32,247,552 and $ 31,558,338 that were covered by such limited i… |
| HJ-GROUP |
HJ-GROUP |
62%
|
ey Personnel is incorporated by reference from our 2023 Annual Report under the caption “Contractual Arrangements with HJ Group and the Key Personnel.” Corporate Information Our principal executive o… |
| HONG-KONG-CO-LTD |
HONG-KONG-CO-LTD |
62%
|
ingly, the Consolidated Statements of Cash Flows include the results of continuing and discontinued operations. Refer to Note 4 - Discontinued Operations for further information. The accompanying not… |
| HUADONG-PHARMACEUTICAL-CO-LTD |
HUADONG-PHARMACEUTICAL-CO-LTD |
62%
|
d by reference from our 2023 Annual Report under the caption “Logistics.” Suppliers We currently source retail products from approximately 26 suppliers, including trading companies and direct manufac… |
| JIUZHOUTONG-PHARMACEUTICAL-CO-LTD |
JIUZHOUTONG-PHARMACEUTICAL-CO-LTD |
62%
|
e to make deliveries as necessary. Competition The wholesale pharmaceutical distribution industry in China is competitive and highly fragmented. We compete with regional distributors, such as Zhengch… |
| KERRISDALE-MINING-CORPORATION |
KERRISDALE-MINING-CORPORATION |
62%
|
,577 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid for income taxes $ 149,023 $ 63,668 $ 3,955 Cash paid for interest 13,604 64,943 262,218 NON-CASH ACTIVITIES： Cashless exercise of war… |
| NASDAQ-STOCK-MARKET-LLC |
NASDAQ-STOCK-MARKET-LLC |
62%
|
siness, financial condition and results of operations may be adversely affected if these events occur. For example, epidemics threaten people’s lives and may adversely affect their livelihood as well… |
| PUBLIC-HEALTH-SERVICE-CO-LTD |
PUBLIC-HEALTH-SERVICE-CO-LTD |
62%
|
rol contractually, operates our “Jiuzhou Grand Pharmacy” stores; ● Hangzhou Jiuzhou Clinic of Integrated Traditional and Western Medicine (General Partnership) (“Jiuzhou Clinic”), which we control co… |
| WORKING-GROUP |
WORKING-GROUP |
62%
|
siness, financial condition and results of operations may be adversely affected if these events occur. For example, epidemics threaten people’s lives and may adversely affect their livelihood as well… |
| YCM-CPA-INC |
YCM-CPA-INC |
62%
|
siness, financial condition and results of operations may be adversely affected if these events occur. For example, epidemics threaten people’s lives and may adversely affect their livelihood as well… |
| ZHEJIANG-JIUXIN-INVESTMENT-MANAGEMENT-CO-LTD |
ZHEJIANG-JIUXIN-INVESTMENT-MANAGEMENT-CO-LTD |
62%
|
,577 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid for income taxes $ 149,023 $ 63,668 $ 3,955 Cash paid for interest 13,604 64,943 262,218 NON-CASH ACTIVITIES： Cashless exercise of war… |
| ZHEJIANG-JIUXIN-MEDICINE-CO-LTD |
ZHEJIANG-JIUXIN-MEDICINE-CO-LTD |
62%
|
. HISTORY AND DEVELOPMENT OF THE COMPANY. Overview We are a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People’s Republic of China (“PRC” or “China”). Pr… |
| ZHEJIANG-SHOUANTANG-MEDICAL-TECHNOLOGY-CO-LTD |
ZHEJIANG-SHOUANTANG-MEDICAL-TECHNOLOGY-CO-LTD |
62%
|
,577 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid for income taxes $ 149,023 $ 63,668 $ 3,955 Cash paid for interest 13,604 64,943 262,218 NON-CASH ACTIVITIES： Cashless exercise of war… |
| ZHEJIANG-ZHETONG-MEDICAL-CO-LTD |
ZHEJIANG-ZHETONG-MEDICAL-CO-LTD |
62%
|
formerly known as Zhejiang Zhetong Medical Co., Ltd. Zhuoli Service was established in March 2020 to target potential acquisitions or to cooperate with local pharmacies. By attracting more funds from… |
| ZHEJIANG-ZHUOLI-LIFE-SERVICE-CO |
ZHEJIANG-ZHUOLI-LIFE-SERVICE-CO |
62%
|
C are covered by insurance up to RMB 500,000 (USD 79,600 ) per bank. As of March 31, 2024 and 2023, the Company had deposits totaling $ 32,247,552 and $ 31,558,338 that were covered by such limited i… |
